Literature DB >> 12060314

Analysis by gestational age of cerebral palsy in singleton births in north-east England 1970-94.

P M Drummond1, A F Colver.   

Abstract

We report from a well-established cerebral palsy (CP) register the changes in CP rates by gestational age for singleton births over a 25-year period in north-east England. The gestational ages of numerators and denominators are of high accuracy back to 1970 because academic units in paediatrics and obstetrics were studying the assessment of gestational age in individual infants, and the distribution of gestational age across all births in the north-east from the 1960s. The rate of CP rose between 1970-75 and 1990-94 from 1.6 to 2.3 per 1000 singleton neonatal survivors, a rise of 0.7/1000 [95% CI 0.2, 1.3]. There was little change in the rate of CP in term infants whereas in preterm infants (<37 weeks) it rose from 5.5 to 16.8, a rise of 11.3/1000 [95% CI 5.9, 16.8]. Rises occurred in the three preterm gestational age bands <28, 28-31, 32-36 weeks with the most marked rise in those <28 weeks from 0 to 112.7. The proportion of all cases of CP arising in the preterm group rose from 19% to 45%; and the proportion of the severest cases arising in the preterm group rose from 8% to 55%. In those born after 32 weeks, there is a preponderance of small-for-gestation infants, with 10% more than two standard deviations below the mean. All types of CP are more common in infants below average weight for gestation and this is most marked for the non-spastic types that are almost only seen in term, small-for-gestation infants. Gestational age is the crucial determinant of rate of CP and the increase in prevalence seen over the past 25 years is due to increased rates in preterm infants, not term infants. Both conclusions, suspected from birthweight analyses, are now demonstrated conclusively, with the contribution coming from those 32-36 weeks gestation as well as very preterm infants.

Entities:  

Mesh:

Year:  2002        PMID: 12060314     DOI: 10.1046/j.1365-3016.2002.00408.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  12 in total

1.  Trends in prevalence of cerebral palsy in children born with a birthweight of 2,500 g or over in Europe from 1980 to 1998.

Authors:  Elodie Sellier; Geraldine Surman; Kate Himmelmann; Guro Andersen; Allan Colver; Ingeborg Krägeloh-Mann; Javier De-la-Cruz; Christine Cans
Journal:  Eur J Epidemiol       Date:  2010-06-08       Impact factor: 8.082

2.  Influence of gestational age on nosologic CP characteristics in a high-risk population.

Authors:  Eveline Himpens; Ann Oostra; Inge Franki; Patrick Calders; Piet Vanhaesebrouck; Christine Van den Broeck
Journal:  Eur J Pediatr       Date:  2009-07-16       Impact factor: 3.183

3.  The ELGAN study of the brain and related disorders in extremely low gestational age newborns.

Authors:  T M O'Shea; E N Allred; O Dammann; D Hirtz; K C K Kuban; N Paneth; A Leviton
Journal:  Early Hum Dev       Date:  2009-09-17       Impact factor: 2.079

4.  Influence of gestational age on the type of brain injury and neuromotor outcome in high-risk neonates.

Authors:  Christine Van den Broeck; Eveline Himpens; Piet Vanhaesebrouck; Patrick Calders; Ann Oostra
Journal:  Eur J Pediatr       Date:  2007-11-17       Impact factor: 3.183

5.  Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis.

Authors:  Celeste D Bickford; Laura A Magee; Craig Mitton; Marie Kruse; Anne R Synnes; Diane Sawchuck; Melanie Basso; Vyta M Senikas; Peter von Dadelszen
Journal:  BMC Health Serv Res       Date:  2013-12-19       Impact factor: 2.655

6.  Heart rate characteristics and neurodevelopmental outcome in very low birth weight infants.

Authors:  K Addison; M P Griffin; J R Moorman; D E Lake; T M O'Shea
Journal:  J Perinatol       Date:  2009-06-25       Impact factor: 2.521

Review 7.  Melatonin for women in pregnancy for neuroprotection of the fetus.

Authors:  Dominic Wilkinson; Emily Shepherd; Euan M Wallace
Journal:  Cochrane Database Syst Rev       Date:  2016-03-29

8.  Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.

Authors:  Caroline A Crowther; Philippa F Middleton; Dominic Wilkinson; Pat Ashwood; Ross Haslam
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-09       Impact factor: 3.007

9.  Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE).

Authors: 
Journal:  Syst Rev       Date:  2012-03-21

10.  Does the risk of cerebral palsy increase or decrease with increasing gestational age?

Authors:  K S Joseph; Alexander C Allen; Samawal Lutfi; Lynn Murphy-Kaulbeck; Michael J Vincer; Ellen Wood
Journal:  BMC Pregnancy Childbirth       Date:  2003-12-23       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.